Patents by Inventor Ayako Fukuda

Ayako Fukuda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS
    Publication number: 20200291406
    Abstract: Provided is siRNA effective for the treatment of fibrosis and a pharmaceutical containing the siRNA.
    Type: Application
    Filed: August 1, 2019
    Publication date: September 17, 2020
    Applicants: MIE UNIVERSITY, Otsuka Pharmaceutical Co., Limited
    Inventors: Esteban C GABAZZA, Tetsu KOBAYASHI, Hidekazu TOYOBUKU, Ayako FUKUDA, Tetsuya HASEGAWA
  • PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS
    Publication number: 20190010500
    Abstract: Provided is siRNA effective for the treatment of fibrosis and a pharmaceutical containing the siRNA.
    Type: Application
    Filed: September 24, 2018
    Publication date: January 10, 2019
    Applicants: MIE UNIVERSITY, Otsuka Pharmaceutical Co., Limited
    Inventors: Esteban C. Gabazza, Tetsu Kobayashi, Hidekazu Toyobuku, Ayako Fukuda, Tetsuya Hasegawa
  • Preventive or therapeutic agent for fibrosis
    Patent number: 10125366
    Abstract: Provided is siRNA effective for the treatment of fibrosis and a pharmaceutical containing the siRNA.
    Type: Grant
    Filed: March 22, 2017
    Date of Patent: November 13, 2018
    Assignees: MIE UNIVERSITY, OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Esteban C Gabazza, Tetsu Kobayashi, Hidekazu Toyobuku, Ayako Fukuda, Tetsuya Hasegawa
  • PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS
    Publication number: 20170198293
    Abstract: Provided is siRNA effective for the treatment of fibrosis and a pharmaceutical containing the siRNA.
    Type: Application
    Filed: March 22, 2017
    Publication date: July 13, 2017
    Applicants: Mie University, Otsuka Pharmaceutical Co., Ltd.
    Inventors: Esteban C. GABAZZA, Tetsu KOBAYASHI, Hidekazu TOYOBUKU, Ayako FUKUDA, Tetsuya HASEGAWA
  • Preventive or therapeutic agent for fibrosis
    Patent number: 9637743
    Abstract: Provided is siRNA effective for the treatment of fibrosis and a pharmaceutical containing the siRNA.
    Type: Grant
    Filed: January 19, 2016
    Date of Patent: May 2, 2017
    Assignees: MIE UNIVERSITY, OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Esteban C Gabazza, Tetsu Kobayashi, Hidekazu Toyobuku, Ayako Fukuda, Tetsuya Hasegawa
  • PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS
    Publication number: 20160130586
    Abstract: Provided is siRNA effective for the treatment of fibrosis and a pharmaceutical containing the siRNA.
    Type: Application
    Filed: January 19, 2016
    Publication date: May 12, 2016
    Applicants: Mie University, Otsuka Pharmaceutical Co., Ltd.
    Inventors: Esteban C. Gabazza, Tetsu Kobayashi, Hidekazu Toyobuku, Ayako Fukuda, Tetsuya Hasegawa
  • Preventive or therapeutic agent for fibrosis
    Patent number: 9273314
    Abstract: Provided is siRNA effective for the treatment of fibrosis and a pharmaceutical containing the siRNA.
    Type: Grant
    Filed: May 8, 2014
    Date of Patent: March 1, 2016
    Assignees: MIE UNIVERSITY, OTSUKA PHARMACEUTICAL CO., LTD.
    Inventors: Esteban C Gabazza, Tetsu Kobayashi, Hidekazu Toyobuku, Ayako Fukuda, Tetsuya Hasegawa
  • PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS
    Publication number: 20140288151
    Abstract: Provided is siRNA effective for the treatment of fibrosis and a pharmaceutical containing the siRNA.
    Type: Application
    Filed: May 8, 2014
    Publication date: September 25, 2014
    Applicants: Mie University, Otsuka Pharmaceutical Co., Ltd.
    Inventors: Esteban C GABAZZA, Tetsu Kobayashi, Hidekazu Toyobuku, Ayako Fukuda, Tetsuya Hasegawa
  • Preventive or therapeutic agent for fibrosis
    Patent number: 8772262
    Abstract: Provided is siRNA effective for the treatment of fibrosis and a pharmaceutical containing the siRNA. An siRNA having a full length of 30 or fewer nucleotides and targeting a sequence consisting of 17 to 23 consecutive bases selected from the group consisting of bases at positions 1285 to 1318, bases at positions 1398 to 1418, bases at positions 1434 to 1463, bases at positions 1548 to 1579, bases at positions 1608 to 1628, bases at positions 1700 to 1726, bases at positions 1778 to 1798, bases at positions 1806 to 1826, and bases at positions 1887 to 1907 of SEQ ID NO: 1.
    Type: Grant
    Filed: October 14, 2011
    Date of Patent: July 8, 2014
    Assignees: Mie University, Otsuka Pharmaceutical Co., Ltd.
    Inventors: Esteban C Gabazza, Tetsu Kobayashi, Hidekazu Toyobuku, Ayako Fukuda, Tetsuya Hasegawa
  • PREVENTIVE OR THERAPEUTIC AGENT FOR FIBROSIS
    Publication number: 20130217754
    Abstract: Provided is siRNA effective for the treatment of fibrosis and a pharmaceutical containing the siRNA. An siRNA having a full length of 30 or fewer nucleotides and targeting a sequence consisting of 17 to 23 consecutive bases selected from the group consisting of bases at positions 1285 to 1318, bases at positions 1398 to 1418, bases at positions 1434 to 1463, bases at positions 1548 to 1579, bases at positions 1608 to 1628, bases at positions 1700 to 1726, bases at positions 1778 to 1798, bases at positions 1806 to 1826, and bases at positions 1887 to 1907 of SEQ ID NO: 1.
    Type: Application
    Filed: October 14, 2011
    Publication date: August 22, 2013
    Applicants: OTSUKA PHARMACEUTICAL CO., LTD., MIE UNIVERSITY
    Inventors: Esteban C. Gabazza, Tetsu Kobayashi, Hidekazu Toyobuku, Ayako Fukuda, Tetsuya Hasegawa